In Vitro Study of Extracellular Vesicles Migration in Cartilage-Derived Osteoarthritis Samples Using Real-Time Quantitative Multimodal Nonlinear Optics Imaging.

cartilage coherent anti-stokes raman scattering extracellular vesicles mesenchymal stem cells microscopy osteoarthritis second harmonic generation time-lapse two-photon excitation fluorescence

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
05 Aug 2020
Historique:
received: 14 07 2020
revised: 31 07 2020
accepted: 02 08 2020
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 9 8 2020
Statut: epublish

Résumé

Mesenchymal stromal cells (MSCs)-derived extracellular vesicles (EVs) are promising therapeutic nano-carriers for the treatment of osteoarthritis (OA). The assessment of their uptake in tissues is mandatory but, to date, available technology does not allow to track and quantify incorporation in real-time. To fill this knowledge gap, the present study was intended to develop an innovative technology to determine kinetics of fluorescent MSC-EV uptake by means of time-lapse quantitative microscopy techniques. Adipose-derived mesenchymal stromal cells (ASCs)-EVs were fluorescently labeled and tracked during their uptake into chondrocytes micromasses or cartilage explants, both derived from OA patients. Immunofluorescence and time-lapse coherent anti-Stokes Raman scattering, second harmonic generation and two-photon excited fluorescence were used to follow and quantify incorporation. EVs penetration appeared quickly after few minutes and reached 30-40 μm depth after 5 h in both explants and micromasses. In explants, uptake was slightly faster, with EVs signal overlapping both extracellular matrix and chondrocytes, whereas in micromasses a more homogenous diffusion was observed. The finding of this study demonstrates that this innovative technology is a powerful tool to monitor EVs migration in tissues characterized by a complex extracellular network, and to obtain data resembling in vivo conditions.

Identifiants

pubmed: 32764234
pii: pharmaceutics12080734
doi: 10.3390/pharmaceutics12080734
pmc: PMC7464389
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente

Références

J Tissue Eng Regen Med. 2010 Jul;4(5):387-94
pubmed: 20101620
J Orthop Res. 2005 Mar;23(2):425-32
pubmed: 15734258
Stem Cells. 2017 Apr;35(4):851-858
pubmed: 28294454
Cytotherapy. 2019 Dec;21(12):1179-1197
pubmed: 31784241
Cell Mol Life Sci. 2016 Jan;73(2):445-58
pubmed: 26245304
Stem Cell Res Ther. 2019 Mar 29;10(1):109
pubmed: 30922413
Trends Biotechnol. 2012 Mar;30(3):166-76
pubmed: 22071143
J Extracell Vesicles. 2013 Jan 10;2:
pubmed: 24009896
Theranostics. 2018 Jan 1;8(4):906-920
pubmed: 29463990
Cells. 2019 Nov 27;8(12):
pubmed: 31783568
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Methods Mol Biol. 2015;1340:3-21
pubmed: 26445827
Nat Commun. 2015 Apr 13;6:6798
pubmed: 25865282
Osteoarthritis Cartilage. 2002 Jul;10(7):564-72
pubmed: 12127837
Front Cell Dev Biol. 2016 Aug 22;4:83
pubmed: 27597941
J Anat. 2004 Sep;205(3):229-37
pubmed: 15379928
Cell Commun Signal. 2016 Jan 12;14:2
pubmed: 26754424
Vet J. 2016 Mar;209:40-9
pubmed: 26831151
PLoS One. 2016 Feb 18;11(2):e0147302
pubmed: 26889833
Nat Photonics. 2013 Feb 1;7(2):93-101
pubmed: 24307915
Integr Biol (Camb). 2018 Oct 15;10(10):635-645
pubmed: 30225469
Stem Cells Transl Med. 2019 Sep;8(9):880-886
pubmed: 31045328
J Extracell Vesicles. 2020 Mar 09;9(1):1735249
pubmed: 32284824
Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1 Suppl):23-31
pubmed: 24046946
Stem Cells. 2017 Apr;35(4):1093-1105
pubmed: 28164431
Eur Cell Mater. 2014 Apr 23;27:298-311
pubmed: 24760577
Nanoscale. 2020 Apr 14;12(14):7651-7659
pubmed: 32207761
Theranostics. 2017 Jan 1;7(1):180-195
pubmed: 28042326
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Cell Cycle. 2018 Dec 11;17(24):
pubmed: 30526325
Biomed Res Int. 2014;2014:648459
pubmed: 24959581
Tissue Eng Part A. 2011 May;17(9-10):1425-36
pubmed: 21247341
ACS Cent Sci. 2016 Dec 28;2(12):885-895
pubmed: 28058277
Int J Mol Sci. 2020 Feb 26;21(5):
pubmed: 32111031
Sci Rep. 2017 Nov 24;7(1):16214
pubmed: 29176667
Bone Marrow Transplant. 2019 Aug;54(Suppl 2):789-792
pubmed: 31431712
Osteoarthritis Cartilage. 2016 Dec;24(12):2135-2140
pubmed: 27390028
J Clin Med. 2019 Mar 28;8(4):
pubmed: 30925656
Arthritis Res. 2002;4 Suppl 3:S63-8
pubmed: 12110124
Osteoarthritis Cartilage. 2019 Feb;27(2):230-239
pubmed: 30391394
Cells. 2020 May 09;9(5):
pubmed: 32397409
Stem Cell Res Ther. 2018 Sep 26;9(1):247
pubmed: 30257711
In Vitro Cell Dev Biol. 1989 Jul;25(7):659-68
pubmed: 2666386

Auteurs

Leonardo Mortati (L)

INRIM-Istituto Nazionale di Ricerca Metrologica, 10135 Torino, Italy.

Laura de Girolamo (L)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, via R. Galeazzi 4, 20161 Milano, Italy.

Carlotta Perucca Orfei (C)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, via R. Galeazzi 4, 20161 Milano, Italy.

Marco Viganò (M)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, via R. Galeazzi 4, 20161 Milano, Italy.

Marco Brayda-Bruno (M)

IRCCS Istituto Ortopedico Galeazzi, III Spine Surgery-Scoliosis Department, via R. Galeazzi 4, 20161 Milano, Italy.

Enrico Ragni (E)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, via R. Galeazzi 4, 20161 Milano, Italy.

Alessandra Colombini (A)

IRCCS Istituto Ortopedico Galeazzi, Laboratorio di Biotecnologie Applicate all'Ortopedia, via R. Galeazzi 4, 20161 Milano, Italy.

Classifications MeSH